Companies /Financial Services

aTyr Pharma Inc

NASDAQ: LIFE Insurance Brokers
$33.80
▲ $0.54 (+1.62%) today
Markets open · 2:14pm ET

LIFE at a Glance

Valuation
Market cap
$2.2B
Profitability
Revenue (TTM)
$728.0M
Profit margin
-16.2%
EPS (TTM)
$-2.11
Price
52-week range
$9 – $50
Street target
$53.38

Headquartered in San Francisco, CA Fiscal year ends December NASDAQ: LIFE ethos.com

About Ethos Technologies

Ethos Technologies Inc. (Nasdaq: LIFE) is a life insurance technology company that operates a three-sided technology platform serving consumers, independent agents and insurance carriers. Ethos sells instant, accessible life insurance products through a fully online process that requires no medical exams and only a few health questions. It earns commission revenue from carriers on activated policies.

The company distributes through two channels:
- **Direct Channel:** consumer-facing sales.
- **Third-Party Channel:** agent and partner-driven distribution, which has become its fastest-growing channel.

Ethos completed an initial public offering of Class A common stock in 2026, converting its redeemable convertible preferred stock. In the third quarter of 2026 its board authorized a share repurchase program of up to $100 million. Updated

Latest Activity

LIFEEthos Technologies
Q3 2026
EPS
$0.49
est $0.35+38.8%
Revenue
$235M
est $169M+39.2%

Ethos activated 142,111 new life policies, up 189% year over year, exceeding expectations on both lines. Growth is costing more: contribution margin narrowed to 28% from 39% as marketing spend more than doubled.

Quarterly EPS — reported vs estimate

LIFE Coverage

11:05am ET
Health and Healthcare

Wednesday’s Top Biopharma Winners

Trump said last week that companies in the health care sector are “getting away with murder,” and that something had to change. The sector has pulled back slightly since then, but there…

Chris Lange
10:45am ET
Health and Healthcare

aTyr Pharma Drops on Clinical Update

aTyr Pharma shares dropped early on Tuesday after the company announced clinical results from its exploratory trials assessing the safety and potential activity of Resolaris.

Chris Lange
10:15am ET
Health and Healthcare

aTyr Receives FDA Fast Track Designation

aTyr Pharma watched its shares climb early on Monday after the company announced that its product candidate Resolaris was granted Fast Track designation by the FDA.

Chris Lange
4:04pm ET
Investing

The 52-Week Low Club for Friday

April 8, 2016: Here are four stocks trading with relatively heavy volume among 22 equities making new 52-week lows in Friday’s session. The day’s NYSE winners led losers by about 3-to-1. The…

Paul Ausick
9:15am ET
Health and Healthcare

Thermo Fisher to Acquire Life Technologies

ThinkstockThe world’s second largest maker of laboratory equipment, Thermo Fisher Scientific Inc. (NYSE: TMO) has agree to acquire competitor Life Technologies Corp. (NASDAQ: LIFE) for $13.6 billion in cash ($76 a share).…

Paul Ausick

Frequently Asked Questions

What does Ethos Technologies do?

Ethos Technologies Inc. (Nasdaq: LIFE) is a life insurance technology company that operates a three-sided technology platform serving consumers, independent agents and insurance carriers.

What is the LIFE stock price target?

The Wall Street consensus 12-month price target for LIFE is $53.38.